JP7598613B2 - ATP production promoter - Google Patents
ATP production promoter Download PDFInfo
- Publication number
- JP7598613B2 JP7598613B2 JP2020160818A JP2020160818A JP7598613B2 JP 7598613 B2 JP7598613 B2 JP 7598613B2 JP 2020160818 A JP2020160818 A JP 2020160818A JP 2020160818 A JP2020160818 A JP 2020160818A JP 7598613 B2 JP7598613 B2 JP 7598613B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- atp production
- extraction
- atp
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002407 ATP formation Effects 0.000 title claims description 46
- 239000000284 extract Substances 0.000 claims description 73
- 241001105098 Angelica keiskei Species 0.000 claims description 17
- 240000006063 Averrhoa carambola Species 0.000 claims description 12
- 235000010082 Averrhoa carambola Nutrition 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 201000004384 Alopecia Diseases 0.000 claims description 2
- 231100000360 alopecia Toxicity 0.000 claims description 2
- 238000000605 extraction Methods 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 20
- 235000013305 food Nutrition 0.000 description 19
- 235000006040 Prunus persica var persica Nutrition 0.000 description 17
- 244000144730 Amygdalus persica Species 0.000 description 16
- 239000002994 raw material Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 241000202807 Glycyrrhiza Species 0.000 description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 9
- 229940010454 licorice Drugs 0.000 description 9
- 229940069445 licorice extract Drugs 0.000 description 9
- 229940079989 star fruit extract Drugs 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4
- -1 and the like Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 3
- 239000012752 auxiliary agent Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 235000011446 Amygdalus persica Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 235000011158 Prunus mume Nutrition 0.000 description 2
- 244000018795 Prunus mume Species 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 241000125175 Angelica Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 244000118154 Aralia spinosa Species 0.000 description 1
- 235000007650 Aralia spinosa Nutrition 0.000 description 1
- 235000014417 Averrhoa Nutrition 0.000 description 1
- 241001072280 Averrhoa Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000208165 Oxalidaceae Species 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
Description
本発明は、ATP産生促進剤に関する。 The present invention relates to an ATP production promoter.
ATP(Adenosine triphosphate;アデノシン三リン酸)は、生体のエネルギー物質として重要な役割を果たしている。生体内におけるATPの産生量を上げることにより、細胞の増殖、代謝、修復等の機能の活性化につながると考えられている。 ATP (Adenosine triphosphate) plays an important role as an energy substance in the body. It is believed that increasing the amount of ATP produced in the body will lead to the activation of functions such as cell proliferation, metabolism, and repair.
生体内のエネルギー物質として重要な役割を担うATPの産生能が低下すると、細胞の機能が低下し、老化や細胞死の促進につながる。低下した細胞の機能を促進させるためには、細胞分裂に必要なエネルギーを細胞に補給することが重要である。細胞におけるATPの産生を促進することができれば、その細胞を活性化して細胞分裂を促し、その細胞の機能を回復することができると考えられる。ATPの産生を促進することは、細胞の増殖、代謝、修復等の機能の活性化につながるとともに抗老化(アンチエイジング)の効果を奏することにも期待される。従来、ATP産生促進作用を有するものとして、大麦若葉(特許文献1)、白金族金属コロイド(特許文献2)、グリコーゲン(特許文献3)等が知られている。 When the ability to produce ATP, which plays an important role as an energy substance in the body, decreases, cell function decreases, leading to accelerated aging and cell death. In order to promote the decreased function of cells, it is important to supply the cells with the energy necessary for cell division. It is believed that if ATP production in cells can be promoted, the cells can be activated to promote cell division and restore the cell's function. Promoting ATP production not only leads to the activation of functions such as cell proliferation, metabolism, and repair, but is also expected to have an anti-aging effect. Barley leaves (Patent Document 1), platinum group metal colloids (Patent Document 2), glycogen (Patent Document 3), etc. are known to have the effect of promoting ATP production.
本発明は、安全性の高い天然物の中からATP産生促進作用を有するものを見出し、それを有効成分とするATP産生促進剤を提供することを目的とする。 The present invention aims to find safe natural products that have an ATP production promoting effect and to provide an ATP production promoter that contains the product as an active ingredient.
このような目的を達成するために、本発明は、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物から選ばれる1種または2種以上を有効成分として含有するATP産生促進剤を提供する。 To achieve this objective, the present invention provides an ATP production promoter containing, as an active ingredient, one or more selected from Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract.
本発明によれば、安全性の高い天然物の中からATP産生促進作用を有するものを見出し、それを有効成分とするATP産生促進剤を提供することができる。 The present invention makes it possible to find safe natural products that have an ATP production promoting effect, and to provide an ATP production promoting agent that contains such products as active ingredients.
本発明の実施の形態について説明する。
本実施形態に係るATP産生促進剤は、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物から選ばれる1種または2種以上を有効成分として含有する。
An embodiment of the present invention will be described.
The ATP production promoter according to this embodiment contains, as an active ingredient, one or more selected from an extract of Angelica keiskei, an extract of star fruit, an extract of plum, an extract of peach, and an extract of licorice.
本実施形態において使用される抽出原料は、アシタバ(学名:Angelica keiskei)、スターフルーツ(学名:Averrhoa carambola)、ウメ(学名:Prunus mume Siebold et Zuccarini)、モモ(学名:Prunus persica Batsch)、及び甘草である。 The extraction raw materials used in this embodiment are angelica tree (scientific name: Angelica keiskei), star fruit (scientific name: Averrhoa carambola), plum (scientific name: Prunus mume Siebold et Zuccarini), peach (scientific name: Prunus persica Batsch), and licorice.
アシタバ(Angelica keiskei)は、房総半島、伊豆半島、伊豆半島等に自生しているセリ科シシウド属に属する多年草であり、これらの地域から容易に入手され得る。抽出原料として使用し得るアシタバの構成部位としては、例えば、葉部、茎部、花部、蕾部、果実部、果皮部、果核部、根部、またはこれらの混合物等が挙げられるが、好ましくは葉部及び/又は茎部である。 Angelica keiskei is a perennial plant of the Apiaceae family that grows naturally in the Boso Peninsula, Izu Peninsula, and other areas, and can be easily obtained from these areas. Components of Angelica keiskei that can be used as the raw material for extraction include, for example, leaves, stems, flowers, buds, fruits, peels, pits, roots, or mixtures thereof, with leaves and/or stems being preferred.
スターフルーツ(Averrhoa carambola)は、カタバミ科ゴレンシ属に属し、新鮮な果実は食用にされる。スターフルーツは、沖縄、中国東南部や雲南その他熱帯各地で栽培されており、これらの地域から容易に入手され得る。抽出原料として使用し得るスターフルーツの構成部位としては、例えば、葉部、幹部、花部、蕾部、果実部、種子部、根部、またはこれらの混合物等が挙げられるが、好ましくは葉部である。 Star fruit (Averrhoa carambola) belongs to the genus Averrhoa in the family Oxalidaceae, and its fresh fruit is edible. Star fruit is cultivated in Okinawa, southeastern China, Yunnan, and other tropical regions, and can be easily obtained from these regions. Components of star fruit that can be used as the raw material for extraction include, for example, leaves, trunks, flowers, buds, fruits, seeds, roots, or mixtures of these, with leaves being preferred.
ウメ(Prunus mume Siebold et Zuccarini)は、バラ科に属する落葉小高木であって、中国や日本で古くから栽培されており、これらの地域から容易に入手され得る。抽出原料として使用し得るウメの構成部位としては、例えば、葉部、枝部、樹皮部、幹部、茎部、花部、蕾部、果実部、果肉部、果皮部、根部、またはこれらの混合物等が挙げられるが、好ましくは果実部又は果肉部である。 Prunus mume Siebold et Zuccarini is a deciduous tree belonging to the Rosaceae family that has been cultivated since ancient times in China and Japan and can be easily obtained from these regions. Examples of parts of the plum tree that can be used as the raw material for extraction include leaves, branches, bark, trunks, stems, flowers, buds, fruits, pulp, peel, roots, and mixtures thereof, with the fruits and pulp being preferred.
モモ(Prunus persica Batsch)は、バラ科サクラ属に属する落葉小高木であって、中国や日本で古くから栽培されており、これらの地域から容易に入手され得る。抽出原料として使用し得るモモの構成部位としては、例えば、葉部、幹部、枝部、花部、蕾部、果実部、果皮部、果核部、種子部、地上部又はこれらの混合物等が挙げられるが、好ましくは葉部である。 Peach (Prunus persica Batsch) is a deciduous tree of the genus Prunus in the family Rosaceae. It has been cultivated since ancient times in China and Japan and can be easily obtained from these regions. The constituent parts of peach that can be used as the extraction raw material include, for example, leaves, trunks, branches, flowers, buds, fruit, peel, pulp, seeds, above-ground parts, and mixtures of these, with leaves being preferred.
甘草は、マメ科グリチルリーザ(Glycyrrhiza)属に属する多年生草本である。甘草には、グリチルリーザ・グラブラ(Glycyrrhiza glabra)、グリチルリーザ・インフラータ(Glycyrrhiza inflata)、グリチルリーザ・ウラレンシス(Glycyrrhiza uralensis)等、様々な種類のものがあり、これらを抽出原料として使用することが好ましい。抽出原料として使用し得る甘草の構成部位としては、例えば、葉部、枝部、樹皮部、幹部、茎部、果実部、種子部、花部、根部又はこれらの混合物等が挙げられるが、好ましくは葉部である。 Licorice is a perennial herb belonging to the genus Glycyrrhiza of the family Fabaceae. There are various kinds of licorice , such as Glycyrrhiza glabra , Glycyrrhiza inflata, and Glycyrrhiza uralensis, and it is preferable to use these as the extraction raw material. The constituent parts of licorice that can be used as the extraction raw material include, for example, leaves, branches, bark, trunks, stems, fruits, seeds, flowers, roots, or mixtures thereof, and the like, and the leaves are preferred.
上記の抽出原料からの抽出物に含まれるATP産生促進作用を有する物質の詳細は不明であるが、植物の抽出等に一般に用いられている抽出方法によって、上記抽出原料からATP産生促進作用を有する抽出物を得ることができる。なお、抽出物には、抽出処理によって抽出原料から得られる抽出液、抽出液の希釈液もしくは濃縮液、抽出液を乾燥して得られる乾燥物、またはこれらの粗精製物もしくは精製物のいずれもが含まれる。 Although the details of the substances having an ATP production promoting effect contained in the extract from the above-mentioned extraction raw material are unknown, an extract having an ATP production promoting effect can be obtained from the above-mentioned extraction raw material by an extraction method generally used for plant extraction, etc. The extract includes the extract obtained from the extraction raw material by extraction processing, a diluted or concentrated extract, a dried product obtained by drying the extract, or any of these crude or purified products.
上記抽出物は、抽出原料を乾燥した後、そのまま、または粗砕機を用いて粉砕し、抽出溶媒による抽出に供することにより得ることができる。乾燥は天日で行ってもよいし、通常使用される乾燥機を用いて行ってもよい。また、ヘキサン等の非極性溶媒によって脱脂等の前処理を施してから抽出原料として使用してもよい。脱脂等の前処理を行うことにより、植物の極性溶媒による抽出処理を効率よく行うことができる。 The above extract can be obtained by drying the extraction raw material, either as is or after crushing using a crusher, and then subjecting it to extraction using an extraction solvent. Drying can be performed in the sun or using a commonly used dryer. The raw material can also be used after pretreatment such as degreasing with a non-polar solvent such as hexane. Pretreatment such as degreasing allows the plant to be extracted efficiently using a polar solvent.
抽出に用いられる溶媒としては、水、親水性有機溶媒、またはこれらの混合物等が挙げられ、室温または溶媒の沸点以下の温度で使用することが好ましい。各抽出原料に含まれるATP産生促進作用を有する成分は、極性溶媒を抽出溶媒とする抽出処理によって容易に抽出することができる。 Solvents used for extraction include water, hydrophilic organic solvents, or mixtures of these, and are preferably used at room temperature or at a temperature below the boiling point of the solvent. Components that have the effect of promoting ATP production contained in each extraction raw material can be easily extracted by an extraction process using a polar solvent as the extraction solvent.
抽出溶媒として使用し得る水としては、例えば、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等の他、これらに各種処理を施したものが含まれる。水に施す処理としては、例えば、精製、加熱、殺菌、濾過、イオン交換、浸透圧の調整、緩衝化等が含まれる。従って、本発明において抽出溶媒として使用し得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。 Examples of water that can be used as an extraction solvent include pure water, tap water, well water, mineral water, hot spring water, spring water, fresh water, and the like, as well as water that has been subjected to various treatments. Treatments that can be applied to water include, for example, purification, heating, sterilization, filtration, ion exchange, adjustment of osmotic pressure, buffering, and the like. Thus, water that can be used as an extraction solvent in the present invention also includes purified water, hot water, ion-exchanged water, saline, phosphate buffer, phosphate buffered saline, and the like.
抽出溶媒として使用し得る親水性有機溶媒としては、例えば、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の炭素数1~5の低級脂肪族アルコール;アセトン、メチルエチルケトン等の低級脂肪族ケトン;1,3-ブチレングリコール、プロピレングリコール、グリセリン等の炭素数2~5の多価アルコール等が挙げられる。 Examples of hydrophilic organic solvents that can be used as extraction solvents include lower aliphatic alcohols with 1 to 5 carbon atoms, such as methanol, ethanol, propyl alcohol, and isopropyl alcohol; lower aliphatic ketones, such as acetone and methyl ethyl ketone; and polyhydric alcohols with 2 to 5 carbon atoms, such as 1,3-butylene glycol, propylene glycol, and glycerin.
2種以上の極性溶媒の混合液を抽出溶媒として使用する場合、その混合比は適宜調整することができる。例えば、水と低級脂肪族アルコールとの混合液を使用する場合には水10容量部に対して低級脂肪族アルコール1~90容量部を混合することが好ましい。水と脂肪族ケトンとの混合液を使用する場合には、水10容量部に対して低級脂肪族ケトン1~40容量部を混合することが好ましい。水と多価アルコールとの混合液を使用する場合には、水10容量部に対して多価アルコール1~90容量部を混合することが好ましい。 When a mixture of two or more polar solvents is used as the extraction solvent, the mixing ratio can be adjusted as appropriate. For example, when using a mixture of water and a lower aliphatic alcohol, it is preferable to mix 1 to 90 parts by volume of the lower aliphatic alcohol with 10 parts by volume of water. When using a mixture of water and an aliphatic ketone, it is preferable to mix 1 to 40 parts by volume of the lower aliphatic ketone with 10 parts by volume of water. When using a mixture of water and a polyhydric alcohol, it is preferable to mix 1 to 90 parts by volume of the polyhydric alcohol with 10 parts by volume of water.
抽出処理は、抽出原料に含まれる可溶性成分を抽出溶媒に溶出させ得る限り特殊な抽出方法を採用する必要はなく、室温または還流加熱下で抽出することができる。例えば、抽出溶媒を満たした処処理槽に各抽出原料を投入し、必要に応じて撹拌しながら、30分~4時間静置して可溶性成分を溶出した後、濾過して固形物を除去することにより抽出物を得ることができる。得られた抽出液から抽出溶媒を留去するとペースト状の濃縮物が得られ、この濃縮物をさらに乾燥することにより乾燥物が得られる。抽出条件は、抽出溶媒として水を用いた場合には50~95℃で1~4時間程度である。また、抽出溶媒として水とエタノールとの混合溶媒を用いた場合には、40~80℃で30分~4時間程度である。 As long as the soluble components contained in the raw materials can be dissolved in the extraction solvent, there is no need to use a special extraction method, and extraction can be performed at room temperature or under reflux heating. For example, each raw material is placed in a treatment tank filled with the extraction solvent, and the soluble components are dissolved by leaving it to stand for 30 minutes to 4 hours while stirring as necessary, and then the solid matter is removed by filtration to obtain an extract. The extraction solvent is distilled off from the obtained extract to obtain a paste-like concentrate, and this concentrate is further dried to obtain a dried product. The extraction conditions are 50 to 95°C for about 1 to 4 hours when water is used as the extraction solvent. Also, when a mixture of water and ethanol is used as the extraction solvent, the extraction conditions are 40 to 80°C for about 30 minutes to 4 hours.
以上のようにして得られた抽出液は、該抽出液の希釈液もしくは濃縮液、該抽出液の乾燥物、またはこれらの粗精製物もしくは精製物を得るために、常法に従って希釈、濃縮、乾燥、精製等の処理を施してもよい。 The extract obtained in the above manner may be subjected to treatments such as dilution, concentration, drying, purification, etc. according to conventional methods to obtain a diluted or concentrated solution of the extract, a dried product of the extract, or a crude or purified product thereof.
なお、得られた抽出液はそのままでもATP産生促進剤として使用することができるが、濃縮液または乾燥物としたもののほうが好ましい。乾燥物を得るにあたっては、吸湿性を改善するためにデキストリン、シクロデキストリン等のキャリアーを添加してもよい。 The resulting extract can be used as an ATP production promoter as is, but a concentrated liquid or dried product is preferable. When obtaining a dried product, a carrier such as dextrin or cyclodextrin may be added to improve hygroscopicity.
また、各抽出原料は特有の匂いと味を有しているため、その生理活性の低下を招かない範囲で脱色、脱臭等を目的とする精製を行うことも可能であるが、化粧料に添加する場合には大量に使用するものではないから、未精製のままでも実用上支障はない。精製は、例えば活性炭処理、吸着樹脂処理、イオン交換樹脂処理等によって行うことができる。 In addition, since each of the extracted raw materials has a unique odor and taste, it is possible to purify them for the purpose of decolorization, deodorization, etc., to the extent that this does not result in a decrease in their physiological activity. However, since they are not used in large quantities when added to cosmetics, there is no practical problem in using them unrefined. Purification can be carried out, for example, by treatment with activated carbon, adsorption resin, ion exchange resin, etc.
以上のようにして得られるアシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物は、ATP産生促進作用を有しているため、その作用を利用してATP産生促進剤の有効成分として用いられ得る。 The Angelica extract, star fruit extract, plum extract, peach extract, and licorice extract obtained in the manner described above have an ATP production promoting effect, and therefore can be used as an active ingredient of an ATP production promoter by utilizing this effect.
なお、本実施形態に係るATP産生促進剤においては、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物のうちのいずれか1種を上記有効成分として用いてもよいし、それらのうちの2種以上を混合して上記有効成分として用いてもよい。アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物のうちの2種以上を混合して上記有効成分として用いる場合、その配合比は、それらの作用の程度に応じて適宜決定されればよい。 In the ATP production promoter according to this embodiment, any one of Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract may be used as the active ingredient, or two or more of them may be mixed and used as the active ingredient. When two or more of Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract are mixed and used as the active ingredient, the mixing ratio may be appropriately determined according to the degree of their action.
本実施形態に係るATP産生促進剤は、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物から選ばれる1種または2種以上を製剤化したものであってもよい。 The ATP production promoter according to this embodiment may be a formulation of one or more selected from Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract.
上記抽出物は、デキストリン、シクロデキストリン等の薬学的に許容し得るキャリアーその他任意の助剤を用いて、常法に従い、粉末状、顆粒状、液状等の任意の剤形に製剤化することができる。この際、助剤としては、例えば、賦形剤、安定剤、矯臭剤等を用いることができる。上記抽出物を製剤化したATP産生促進剤の形態としては、例えば、軟膏剤、外用液剤等が挙げられる。 The above extract can be formulated into any dosage form, such as powder, granules, liquid, etc., in accordance with conventional methods using pharma- ceutically acceptable carriers such as dextrin, cyclodextrin, and other optional auxiliary agents. In this case, examples of auxiliary agents that can be used include excipients, stabilizers, and odorants. Examples of the form of the ATP production promoter prepared by formulating the above extract include ointments, external liquids, etc.
本実施形態に係るATP産生促進剤は、例えば、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物が有するATP産生促進作用を通じて、例えば毛乳頭細胞におけるATPの産生を促進することができ、これによる種々の用途(例えば、脱毛症等の予防・改善用途等)に用いることができる。ただし、本実施形態に係るATP産生促進剤は、この用途以外にもATP産生促進作用を発揮する意義のあるすべての用途に用いることができる。 The ATP production promoter according to this embodiment can promote ATP production in hair papilla cells, for example, through the ATP production promoting action of extracts of Angelica keiskei, star fruit, plum, peach, and licorice, and can be used for various applications (for example, applications for preventing and improving alopecia, etc.). However, the ATP production promoter according to this embodiment can be used for all applications in which it is meaningful to exert an ATP production promoting action in addition to this application.
また、本実施形態に係るATP産生促進剤、またはアシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物から選ばれる1種または2種以上は、優れたATP賛成促進作用を有するため、皮膚化粧料、頭皮化粧料、頭髪化粧料等の化粧料や、飲食品等に配合するのに好適である。 In addition, the ATP production promoter according to this embodiment, or one or more selected from Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract, have excellent ATP production promoting effects, and are therefore suitable for incorporation into cosmetics such as skin cosmetics, scalp cosmetics, and hair cosmetics, as well as into foods, beverages, and the like.
アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物から選ばれる1種または2種以上や、上記ATP産生促進剤を配合可能な化粧料としては、例えば、軟膏、クリーム、乳液、ローション、パック、ファンデーション、ヘアトニック、ヘアローション、シャンプー、リンス、石鹸等が挙げられる。上記抽出物やATP産生促進剤を化粧料に配合する場合、その配合量は、化粧料の種類に応じて適宜調整することができるが、好適な配合率は、標準的な抽出物に換算して約0.0001~10質量%であり、特に好適な配合率は、標準的な抽出物に換算して約0.001~1質量%である。化粧料は、上記抽出物が有するATP産生促進作用を妨げない限り、通常の化粧料の製造に用いられる主剤、助剤またはその他の成分、例えば、収斂剤、殺菌・抗菌剤、美白剤、紫外線吸収剤、保湿剤、細胞賦活剤、消炎・抗アレルギー剤、抗酸化・活性酸素除去剤、油脂類、ロウ類、炭化水素類、脂肪酸類、アルコール類、エステル類、界面活性剤、香料等を併用することができる。このように併用することで、より一般性のある製品となり、また、併用された他の有効成分との間の相乗作用が通常期待される以上の優れた効果をもたらすことがある。 Cosmetics that can be blended with one or more selected from Angelica keiskei extract, star fruit extract, plum extract, peach extract, and licorice extract, or the above-mentioned ATP production promoter, include, for example, ointments, creams, milky lotions, lotions, packs, foundations, hair tonics, hair lotions, shampoos, rinses, soaps, etc. When blending the above-mentioned extracts or ATP production promoters into cosmetics, the blending amount can be adjusted appropriately depending on the type of cosmetic, but a suitable blending ratio is about 0.0001 to 10% by mass converted into a standard extract, and a particularly suitable blending ratio is about 0.001 to 1% by mass converted into a standard extract. As long as the ATP production promoting effect of the extract is not hindered, the cosmetic preparation may be used in combination with the main ingredient, auxiliary agent, or other ingredient used in the manufacture of ordinary cosmetic preparations, such as astringents, germicides/antibacterial agents, whitening agents, UV absorbers, moisturizers, cell activators, anti-inflammatory/anti-allergic agents, antioxidants/active oxygen removers, oils and fats, waxes, hydrocarbons, fatty acids, alcohols, esters, surfactants, fragrances, etc. Using the extract in combination in this way can result in a more general product, and the synergistic effect with the other active ingredients used in combination can bring about a superior effect than would normally be expected.
飲食品とは、人の健康に危害を加えるおそれが少なく、通常の社会生活において、経口または消化管投与により摂取されるものをいい、行政区分上の食品、医薬品、医薬部外品等の区分に制限されるものではない。したがって、本実施形態に係る「飲食品」は、経口的に摂取される一般食品、健康食品(機能性飲食品)、保健機能食品(特定保健用食品、栄養機能食品、機能性表示食品)、医薬部外品、医薬品等を構成する組成物を幅広く含むものである。本実施形態における飲食品は、当該飲食品又はその容器や包装、その販促物等に上記抽出物が有するATP産生促進作用が表示されているものであってもよいし、保健機能食品(特定保健用食品、機能性表示食品、栄養機能食品)、医薬部外品又は医薬品であってもよい。 Food and drink refers to food and drink that is unlikely to be harmful to human health and is taken orally or by administration through the digestive tract in normal social life, and is not limited to administrative classifications such as food, medicine, and quasi-drug. Therefore, the "food and drink" according to this embodiment includes a wide range of compositions that constitute general foods, health foods (functional food and drink), health functional foods (foods for specified health uses, foods with nutrient functions, foods with functional claims), quasi-drugs, medicines, etc., that are taken orally. The food and drink according to this embodiment may be one that displays the ATP production promoting effect of the extract on the food and drink, its container or packaging, its promotional materials, etc., or may be a health functional food (foods for specified health uses, foods with functional claims, foods with nutrient functions), quasi-drugs, or medicines.
上記抽出物、又は上記抽出物から製剤化したATP産生促進剤を飲食品に配合する場合、それらにおける有効成分の配合量は、使用目的、症状、性別等を考慮して適宜変更することができるが、添加対象となる飲食品の一般的な摂取量を考慮して、成人1日あたりの抽出物摂取量が約1~1000mgになるようにするのが好ましい。なお、添加対象飲食品が顆粒状、錠剤状又はカプセル状の形態である場合、上記抽出物、又は上記抽出物から製剤化したATP産生促進剤の添加量は、添加対象飲食品に対して通常0.1~100質量%であり、好ましくは5~100質量%である。 When the above extract or the ATP production promoter formulated from the above extract is added to a food or drink, the amount of active ingredient can be changed as appropriate taking into consideration the purpose of use, symptoms, sex, etc., but it is preferable to have an adult daily intake of about 1 to 1000 mg of the extract, taking into consideration the general intake of the food or drink to which it is added. Note that when the food or drink to which it is added is in the form of granules, tablets, or capsules, the amount of the above extract or the ATP production promoter formulated from the above extract added is usually 0.1 to 100% by mass, and preferably 5 to 100% by mass, of the food or drink to which it is added.
なお、本実施形態に係るATP産生促進剤はヒトに対して好適に適用されるものであるが、ATP産生促進効果が奏される限り、ヒト以外の動物に対して適用することも可能である。 The ATP production promoter according to this embodiment is preferably applied to humans, but it can also be applied to animals other than humans as long as it has an ATP production promoting effect.
以下、製造例及び試験例を示し、本発明を具体的に説明するが、本発明は下記の製造例及び試験例等により何ら制限されるものではない。 The present invention will be specifically explained below with reference to the following manufacturing examples and test examples, but the present invention is not limited in any way by the following manufacturing examples and test examples.
〔製造例1〕アシタバ抽出物の製造
アシタバの葉部及び茎部の乾燥物100gに70容量%ブチレングリコール1500mLを加え、80~90℃にて2時間加熱抽出を行い熱時濾過した。得られた抽出液を乾燥してアシタバ抽出物(15g)を得た。
[Production Example 1] Production of Angelica keiskei extract 1500 mL of 70% by volume butylene glycol was added to 100 g of dried leaves and stems of Angelica keiskei, and extraction was carried out by heating at 80 to 90° C. for 2 hours and hot filtration was performed. The obtained extract was dried to obtain Angelica keiskei extract (15 g).
〔製造例2〕スターフルーツ抽出物の製造
スターフルーツの葉部の乾燥物100gに80容量%エタノール1500mLを加え、還流抽出器を用いて80~90℃にて2時間還流抽出を行い熱時濾過した。得られた抽出液を乾燥してスターフルーツ葉抽出物(10g)を得た。
[Production Example 2] Production of starfruit extract 1500 mL of 80% by volume ethanol was added to 100 g of dried starfruit leaves, and reflux extraction was carried out at 80 to 90°C for 2 hours using a reflux extractor, followed by hot filtration. The resulting extract was dried to obtain a starfruit leaf extract (10 g).
〔製造例3〕ウメ抽出物の製造
ウメ果実から得られた果肉部100gに50容量%ブチレングリコールを加えて混合し、濾過した。得られた抽出液を乾燥してウメ抽出物(4g)を得た。
[Production Example 3] Production of plum extract 50% by volume of butylene glycol was added to 100 g of the flesh obtained from plum fruit, mixed and filtered. The obtained extract was dried to obtain plum extract (4 g).
〔製造例4〕モモ抽出物の製造
モモの葉部の乾燥物100gに30容量%ブチレングリコール1500mLを加え、80~90℃にて2時間加熱抽出を行い熱時濾過した。得られた抽出液を乾燥してモモ葉抽出物(24g)を得た。
[Production Example 4] Production of peach extract 1500 mL of 30% by volume butylene glycol was added to 100 g of dried peach leaves, and extraction was carried out by heating at 80 to 90°C for 2 hours, followed by hot filtration. The obtained extract was dried to obtain a peach leaf extract (24 g).
〔製造例5〕甘草抽出物の製造
甘草の葉部の乾燥物100gに70容量%エタノール1500mLを加え、還流抽出器を用いて80~90℃にて2時間還流抽出を行い熱時濾過した。得られた抽出液を乾燥して甘草葉抽出物(5g)を得た。
[Production Example 5] Production of licorice extract 1500 mL of 70% by volume ethanol was added to 100 g of dried licorice leaves, and reflux extraction was carried out at 80 to 90°C for 2 hours using a reflux extractor, followed by hot filtration. The resulting extract was dried to obtain licorice leaf extract (5 g).
〔試験例〕ATP産生促進作用試験
上記製造例1~5で得られたアシタバ抽出物、スターフルーツ抽出物、ウメ抽出物、モモ抽出物及び甘草抽出物について、下記の方法によりATP産生抑制作用の試験を実施した。
[Test Example] Test for ATP production promoting effect The Angelica keiskei extract, star fruit extract, plum extract, peach extract and licorice extract obtained in Production Examples 1 to 5 above were tested for ATP production inhibiting effect by the following method.
正常ヒト頭髪毛乳頭細胞を、増殖添加剤を含有した毛乳頭細胞増殖培地(タカラバイオ社製)を用いて培養した後、トリプシン処理により細胞を回収した。回収した細胞を、10%FBS含有ダルベッコMEMを用いて1.0×104cells/mLの細胞密度になるように希釈した後、コラーゲンコートした96ウェルプレートに1ウェルあたり200μLずつ播種し、3日間培養した。培養終了後、培地を除去し、無血清ダルベッコMEMに溶解した被検試料を各ウェルに100μL添加し、2時間培養した。 Normal human hair dermal papilla cells were cultured in a dermal papilla cell growth medium (manufactured by Takara Bio Inc.) containing a growth additive, and then the cells were harvested by trypsin treatment. The harvested cells were diluted with Dulbecco's MEM containing 10% FBS to a cell density of 1.0 x 104 cells/mL, and then seeded in a collagen-coated 96-well plate at 200 μL per well and cultured for 3 days. After the culture was completed, the medium was removed, and 100 μL of the test sample dissolved in serum-free Dulbecco's MEM was added to each well and cultured for 2 hours.
ATP産生促進作用は、ホタルルシフェラーゼ発光法を用いて細胞内のATP量を測定することにより評価した。具体的には、培養終了後、『「細胞の」ATP測定試薬』(東洋ビーネット社製)を各ウェルに100μL添加し、反応後の化学発光量を測定した。測定結果から、下記式によりATP産生促進率(%)を算出した。 The ATP production promotion effect was evaluated by measuring the amount of ATP in the cells using the firefly luciferase luminescence method. Specifically, after the end of the culture, 100 μL of "Cellular ATP Measurement Reagent" (manufactured by Toyo B-Net Co., Ltd.) was added to each well, and the amount of chemiluminescence after the reaction was measured. From the measurement results, the ATP production promotion rate (%) was calculated using the following formula.
ATP産生促進率(%)=(A/B)×100
式中の「A」は、被験試料を添加した細胞での化学発光量を表し、「B」は、被験試料無添加の細胞での化学発光量を表す。
ATP production promotion rate (%) = (A/B) x 100
In the formula, "A" represents the amount of chemiluminescence in cells to which a test sample was added, and "B" represents the amount of chemiluminescence in cells to which no test sample was added.
上記試験の結果を表1~5に示す。なお、上記式において、被験試料無添加のATP産生促進率は100%となる。 The results of the above tests are shown in Tables 1 to 5. In the above formula, the ATP production promotion rate without the addition of the test sample is 100%.
表1~5に示すように、アシタバの抽出物、スターフルーツの抽出物、ウメの抽出物、モモの抽出物、及び甘草の抽出物は、いずれも高いATP産生促進率を示した。この結果から、これらの抽出物は、優れたATP産生促進作用を有することが確認された。 As shown in Tables 1 to 5, the extracts of Angelica keiskei, star fruit, plum, peach, and licorice all showed high rates of promoting ATP production. These results confirmed that these extracts have excellent ATP production promoting effects.
本発明のATP産生促進剤は、優れたATP産生促進作用を有するので、化粧料や飲食品等に配合したり、更には研究用の試薬として好適に利用できる。 The ATP production promoter of the present invention has an excellent ATP production promoting effect, so it can be incorporated into cosmetics, food and beverages, etc., and can also be suitably used as a research reagent.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020160818A JP7598613B2 (en) | 2020-09-25 | 2020-09-25 | ATP production promoter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020160818A JP7598613B2 (en) | 2020-09-25 | 2020-09-25 | ATP production promoter |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022053924A JP2022053924A (en) | 2022-04-06 |
| JP2022053924A5 JP2022053924A5 (en) | 2023-09-07 |
| JP7598613B2 true JP7598613B2 (en) | 2024-12-12 |
Family
ID=80996882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020160818A Active JP7598613B2 (en) | 2020-09-25 | 2020-09-25 | ATP production promoter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7598613B2 (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003009811A (en) | 2001-07-02 | 2003-01-14 | Nippon Shinyaku Co Ltd | Food composition |
| JP2003292432A (en) | 2002-04-04 | 2003-10-15 | Noevir Co Ltd | Skin care preparation |
| JP2003321373A (en) | 2002-05-01 | 2003-11-11 | Noevir Co Ltd | Epidermal cell activator and atp production promoter |
| JP2006160655A (en) | 2004-12-06 | 2006-06-22 | Nippon Menaade Keshohin Kk | Muscular activator |
| JP2009084216A (en) | 2007-09-28 | 2009-04-23 | Maruzen Pharmaceut Co Ltd | Atp production promoter and epidermal cell activator |
| JP2009256272A (en) | 2008-04-18 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Atp production promoting agent and epidermal cell activation agent |
| JP2009256270A (en) | 2008-04-18 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Insulin-like growth factor-1 expression promoting agent |
| JP2009263337A (en) | 2008-03-31 | 2009-11-12 | Wakayama Prefecture | Anti-fatigue agent |
| JP2010070461A (en) | 2008-09-16 | 2010-04-02 | Noevir Co Ltd | Skin care preparation for external use |
| JP2011055837A (en) | 2010-10-25 | 2011-03-24 | Maruzen Pharmaceut Co Ltd | Food and drink for beautification |
| JP2015093848A (en) | 2013-11-12 | 2015-05-18 | 丸善製薬株式会社 | Skin cosmetic and hair cosmetic |
| CN106580801A (en) | 2017-01-11 | 2017-04-26 | 陆川县米场镇合美种养专业合作社联合社 | Selenium-rich lemon honey mask |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101484685B1 (en) * | 2013-03-07 | 2015-01-21 | 주식회사 콧데 | Composition comprising Angelica keiskei extract as active ingredient |
-
2020
- 2020-09-25 JP JP2020160818A patent/JP7598613B2/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003009811A (en) | 2001-07-02 | 2003-01-14 | Nippon Shinyaku Co Ltd | Food composition |
| JP2003292432A (en) | 2002-04-04 | 2003-10-15 | Noevir Co Ltd | Skin care preparation |
| JP2003321373A (en) | 2002-05-01 | 2003-11-11 | Noevir Co Ltd | Epidermal cell activator and atp production promoter |
| JP2006160655A (en) | 2004-12-06 | 2006-06-22 | Nippon Menaade Keshohin Kk | Muscular activator |
| JP2009084216A (en) | 2007-09-28 | 2009-04-23 | Maruzen Pharmaceut Co Ltd | Atp production promoter and epidermal cell activator |
| JP2009263337A (en) | 2008-03-31 | 2009-11-12 | Wakayama Prefecture | Anti-fatigue agent |
| JP2009256272A (en) | 2008-04-18 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Atp production promoting agent and epidermal cell activation agent |
| JP2009256270A (en) | 2008-04-18 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Insulin-like growth factor-1 expression promoting agent |
| JP2010070461A (en) | 2008-09-16 | 2010-04-02 | Noevir Co Ltd | Skin care preparation for external use |
| JP2011055837A (en) | 2010-10-25 | 2011-03-24 | Maruzen Pharmaceut Co Ltd | Food and drink for beautification |
| JP2015093848A (en) | 2013-11-12 | 2015-05-18 | 丸善製薬株式会社 | Skin cosmetic and hair cosmetic |
| CN106580801A (en) | 2017-01-11 | 2017-04-26 | 陆川县米场镇合美种养专业合作社联合社 | Selenium-rich lemon honey mask |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022053924A (en) | 2022-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4768238B2 (en) | Profilagrin mRNA expression promoter | |
| JP2008007412A (en) | Involucrin production promoter and epidermal keratinization normalizing agent | |
| JP2008273875A (en) | Stem cell growth factor expression increase inhibitor | |
| JP2014221739A (en) | Type vii collagen expression promoter | |
| JP2009013106A (en) | Xanthone derivatives having an inhibitory action on inflammatory cytokine production, methods for producing them, food preparations comprising the same, cosmetics, anti-inflammatory agents | |
| JP2025100930A (en) | Hyaluronic acid production promoter | |
| JP4672269B2 (en) | Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink | |
| JP2022167197A (en) | Hyaluronic Acid Production Promoter, Epidermal Hyaluronic Acid Production Promoter, and Dermal Hyaluronic Acid Production Promoter | |
| JP7598613B2 (en) | ATP production promoter | |
| JP2005239660A (en) | Precursor lipocyte differentiation promoter | |
| JP2021031417A (en) | Transglutaminase-1 production promoter | |
| JP5836421B2 (en) | Hair growth composition, dermal papilla cell proliferation promoting composition, FGF-7 production promoting composition, VEGF production promoting composition, skin surface blood flow promoting composition and cosmetic | |
| JP7402509B2 (en) | DKK1 expression promoter and whitening agent | |
| JP3935360B2 (en) | Hyaluronic acid production promoter, skin cosmetics and cosmetics | |
| JP3938693B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
| JP5896618B2 (en) | Melanin production inhibitor | |
| JP6629271B2 (en) | Endo180 production promoter | |
| JP5419259B2 (en) | Cosmetics | |
| JP7402478B2 (en) | Nerve growth factor expression inhibitor and semaphorin 3A expression promoter | |
| JP2017048155A (en) | DKK1 expression promoter and whitening agent | |
| JP2023102984A (en) | Endo180 production promoter | |
| JP7315940B2 (en) | fibroblast growth factor-5 expression inhibitor | |
| JP2024145999A (en) | Fibroblast growth factor-5 production inhibitor | |
| JP4261572B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
| JP2024145908A (en) | Prostaglandin D2 production inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230830 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230830 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240717 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240930 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241105 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241125 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7598613 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |